Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Regulus Therapeutics Inc. | Chief Financial Officer | Common Stock | 5.78K | $6.88K | $1.19 | Jan 18, 2024 | Direct |
Regulus Therapeutics Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 462K | May 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RGLS | Regulus Therapeutics Inc. | May 20, 2024 | 1 | $0 | 4 | May 21, 2024 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | Jan 18, 2024 | 1 | -$6.51K | 4 | Jan 18, 2024 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | Jan 12, 2024 | 2 | $0 | 4 | Jan 17, 2024 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | Aug 10, 2023 | 1 | $0 | 4 | Aug 14, 2023 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | Jan 11, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | May 10, 2022 | 1 | $0 | 4 | May 11, 2022 | Chief Financial Officer |
RGLS | Regulus Therapeutics Inc. | Jan 12, 2022 | 1 | $0 | 4 | Jan 26, 2022 | Chief Financial Officer |